(Q38004478)

26 August 2017

1 reference

title

Serotonin agents in anxiety (English)

1 reference

26 August 2017

0 references

Taylor DP

1

1 reference

PubMed ID

2252334

26 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Annals of the New York Academy of Sciences

26 August 2017

1 reference

26 August 2017

600

1 reference

26 August 2017

545-56; discussion 556-7

1 reference

26 August 2017

Buspirone: anxiolytic?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Double-blind comparison of buspirone and clorazepate in anxious outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Review of the side-effect profile of buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Buspirone: an anxiolytic without sedative effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Withdrawal symptoms after six weeks' treatment with diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Comparison of withdrawal of buspirone and diazepam: a placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Investigation of the abuse liability of buspirone in alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Reduction by two benzodiazepines and pentobarbitone of the multiunit activity in substantia nigra, hippocampus, nucleus locus coeruleus and nucleus raphé dorsalis of encéphale isolé rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Raphe unit activity in freely moving cats: Effects of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Potential use of drugs modulating 5HT activity in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

A comparison between atria from control and streptozotocin-diabetic rats: the effects of dietary myoinositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Early postnatal treatment with propranolol affects development of brain amines and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Zacopride: anxiolytic profile in rodent and primate models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

Long-term Treatment of Anxiety and Risk of Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16909.X

10.1111/J.1749-6632.1990.TB16909.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

2252334